Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Anastrozole × Clear all

NCT04469764 2025-07-29

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT04719273 2025-01-08

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

Phase 2 Active not recruiting

Endometrial Neoplasms